For more than four decades, the Cancer Research and Treatment Fund (CR&T) has funded the world’s most promising physician-scientists, equipping them with resources to advance the treatment of various types of blood cancers including myeloproliferative neoplasms (MPNs), leukemia, non-Hodgkin’s lymphoma, Hodgkin’s disease and multiple myeloma as well as other common cancers such as breast and lung cancer.
